Pat Price

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations

Helen Young, R. Baum, U. Cremerius et al. · European Journal of Cancer · 1999 · 1.7K citations · Full text

Positron Emission Tomography, Subclinical Tumour Response, Engineering +11

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations

Martin O. Leach, Kevin M. Brindle, Jeff Evelhoch et al. · British Journal of Cancer · 2005 · 511 citations · Full text

Vascular Disease, Engineering, Oncologic Imaging +25

Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple Cancers

Stuart C. Winter, Francesca M. Buffa, Priyamal Silva et al. · Cancer Research · 2007 · 426 citations · Full text

3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.

Henryk Barthel, Marcel Cleij, David R. Collingridge et al. · PubMed · 2003 · 273 citations

Engineering, Oncologic Imaging, Pathology +17

Important advances in oncology 1996

Pat Price · Surgical Oncology · 1997 · 185 citations

Tumor Biology, Important Advances, Medicine +7